MedPath

Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2002-01-01
Employees
321
Market Cap
-
Website
http://www.reatapharma.com

Clinical Trials

51

Active:42
Completed:7

Trial Phases

3 Phases

Phase 1:36
Phase 3:8
Not Applicable:1

Drug Approvals

1

FDA:1

Drug Approvals

SKYCLARYS

Approval Date
Jan 30, 2024
FDA

Clinical Trials

Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials

Phase 1
36 (80.0%)
Phase 3
8 (17.8%)
Not Applicable
1 (2.2%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.